Whalesbook
Atul Ltd. reported a 15% year-over-year revenue increase for the fourth quarter of fiscal year 2026, reaching INR 16.7 billion. Growth was driven by the Performance & Other Chemicals segment, up 18%, thanks to better volumes and new products. The Life Science Chemical segment, however, saw a more modest 5% revenue rise, supported by herbicides, insecticides, and API products. For the full fiscal year 2026, total revenue grew 12% to INR 62.7 billion.
Net profit for Q4 FY26 jumped 66% year over year to INR 2.1 billion. However, this strong growth was significantly boosted by INR 900 million in other income and a INR 243.8 million reversal of an employee provision. These non-operational items played a key role in the profit figure. Operationally, EBITDA increased 25.7% year over year to INR 2.8 billion. EBITDA margins improved to 17% from 15.4% in the previous year, attributed to operational efficiencies and favorable raw material costs. Full-year FY26 net profit grew 38.2% to INR 6.9 billion.
Atul Ltd. currently trades at a trailing P/E ratio of roughly 29.3x to 34.4x. Future estimates for FY27 and FY28 are around 25.4x and 22.4x, respectively. The company has a market capitalization of about INR 20,000-20,400 crore. Motilal Oswal rates the stock 'BUY' with a target price of INR 8,200, citing in-line revenue and a positive outlook. Analysts hold mixed views, with an average target price of INR 7,467, though some have maintained 'Hold' ratings with lower targets. A key financial strength is that the company is virtually debt-free.
Concerns linger about the sustainability of Atul Ltd.'s reported profitability. The significant boost from non-operational income and one-time adjustments in Q4 FY26 could mask underlying pressures on core operating margins, especially if raw material costs rise or pricing power weakens. While EBITDA margins improved, the mixed segment performance adds to concerns about volatility. The stock's current P/E ratio, trading around 30-34x, appears high when viewed against the company's modest historical sales growth and past profit declines. Some reports suggest the valuation grade has shifted to 'Fair' from 'Expensive', but potential margin compression or slower volume growth could make current valuations challenging to sustain, particularly when compared to faster-growing industry peers.
Atul Ltd.'s historical revenue growth has been modest, with a five-year average annual growth rate around 5.38%. Earnings have also declined over the past five years. While the company operates in the growing specialty chemicals sector, its past growth has lagged the industry median, raising questions about its competitive advantage and ability to gain market share in a fast-changing market.
The Indian specialty chemical sector is expected to grow significantly, fueled by rising domestic demand, government initiatives like 'Make in India,' and global supply chain shifts. Atul Ltd. is positioned to benefit from these positive sector trends, supported by its integrated production. Investors often view leadership continuity positively, and Mr. Samveg Lalbhai was recently reappointed as Managing Director for a five-year term. The board has proposed a dividend of INR 30 per share, showing confidence in its financial health and commitment to shareholders. However, translating the strong sector outlook into consistent, margin-boosting growth will be key for sustained shareholder value.